Comparison
Why is Amphastar Pharmaceuticals, Inc. ?
- The company has declared negative results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at USD 168.87 MM
- ROCE(HY) Lowest at 10.39%
- DEBTORS TURNOVER RATIO(HY) Lowest at 4.93 times
- Along with generating -25.37% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Amphastar Pharmaceuticals, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 579.63 MM
Lowest at USD 168.87 MM
Lowest at 10.39%
Lowest at 4.93 times
Lowest at 459.67
Grown by 19.71% (YoY
Lowest at 2.22 times
Lowest at USD 30.12 MM
Lowest at 17.6 %
Lowest at USD 8.05 MM
Lowest at USD 5.14 MM
Lowest at USD 0.14
Here's what is working for Amphastar Pharmaceuticals, Inc.
Cash and Cash Equivalents
Depreciation (USD MM)
Here's what is not working for Amphastar Pharmaceuticals, Inc.
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Operating Profit to Interest
Debtors Turnover Ratio
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Inventory Turnover Ratio
Raw Material Cost as a percentage of Sales






